Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,305 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00378222 | Autologous Transplantation for Multiple Myeloma | completed | Phase 3 | 324 | University of BolognaOTHER | 0 | Sep 19, 2006 | clinicaltrials |
| NCT00057343 | Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma | terminated | Phase 3 | 400 | BiogenINDUSTRY | 1 | Sep 12, 2006 | clinicaltrials |
| NCT00180882 |
| unknown |
| Phase 3 |
| 260 |
| Gustave Roussy, Cancer Campus, Grand ParisOTHER |
| 1 |
| Sep 11, 2006 |
| clinicaltrials |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | terminated | Phase 2 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00138086 | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma | completed | Phase 2 | 75 | Lymphoma Study AssociationOTHER | 3 | Sep 8, 2006 | clinicaltrials |
| NCT00138112 | Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation | completed | Phase 3 | 126 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00042445 | Brain Neoplasms, Leukemia and Petrochemical Exposures | completed | — | 1,456 | National Institute of Environmental Health Sciences (NIEHS)NIH | 2 | Sep 4, 2006 | clinicaltrials |
| NCT00300001 | Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes | unknown | — | 300 | Community Cancer CareOTHER | 1 | Aug 25, 2006 | clinicaltrials |
| NCT00231712 | Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant | unknown | — | 50 | Julius-Maximilians UniversityOTHER | 1 | Aug 23, 2006 | clinicaltrials |
| NCT00367185 | Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma | completed | Phase 3 | 500 | University Hospital, LilleOTHER | 1 | Aug 22, 2006 | clinicaltrials |
| NCT00067288 | Meaning-Centered Psychotherapy in Advanced Cancer | completed | Phase 2 | 118 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00082303 | Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00336206 | Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia | unknown | N/A | 60 | Tawam HospitalOTHER | 0 | Jul 25, 2006 | clinicaltrials |
| NCT00001533 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | completed | Phase 1 | 25 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 17, 2006 | clinicaltrials |
| NCT00328237 | Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation | unknown | Phase 2 | 20 | Colorado Blood Cancer InstituteOTHER | 1 | Jun 26, 2006 | clinicaltrials |
| NCT00327262 | Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase | unknown | Phase 3 | 240 | Central European Leukemia Study GroupOTHER | 1 | Jun 20, 2006 | clinicaltrials |
| NCT00337506 | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma | terminated | Phase 2 | 50 | Nantes University HospitalOTHER | 1 | Jun 16, 2006 | clinicaltrials |
| NCT00096837 | A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 25 | Pharmacyclics LLC.INDUSTRY | 1 | Jun 8, 2006 | clinicaltrials |
| NCT00044733 | Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant | completed | Phase 2 | 38 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | May 18, 2006 | clinicaltrials |
| NCT00323505 | A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | May 9, 2006 | clinicaltrials |
| NCT00319865 | PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | unknown | Phase 2 | 47 | Korean Multiple Myeloma Working PartyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
| NCT00311337 | VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) | unknown | Phase 2 | 61 | University of WuerzburgOTHER | 3 | Apr 5, 2006 | clinicaltrials |
| NCT00306969 | Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma | completed | Phase 1 / Phase 2 | 18 | Boston UniversityOTHER | 1 | Mar 27, 2006 | clinicaltrials |
| NCT00305149 | Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma | completed | N/A | 130 | Rambam Health Care CampusOTHER | 1 | Mar 21, 2006 | clinicaltrials |
| NCT00301275 | Assessing Free Immunoglobulin Light Chains in Patients With Myeloma | completed | — | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 10, 2006 | clinicaltrials |
| NCT00299351 | A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide. | unknown | Phase 2 | 8 | Royal Marsden NHS Foundation TrustOTHER | 0 | Mar 6, 2006 | clinicaltrials |
| NCT00172562 | Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image | unknown | — | — | National Taiwan University HospitalOTHER | 1 | Mar 1, 2006 | clinicaltrials |
| NCT00153582 | WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML) | unknown | Phase 2 | 25 | Charite University, Berlin, GermanyOTHER | 1 | Feb 22, 2006 | clinicaltrials |
| NCT00054808 | Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 40 | Genta IncorporatedINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00045864 | Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00045877 | Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments | completed | Phase 2 / Phase 3 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00100737 | Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL) | terminated | Phase 2 | 300 | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00035022 | Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas | completed | Phase 1 / Phase 2 | 71 | BioCryst PharmaceuticalsINDUSTRY | 1 | Jan 13, 2006 | clinicaltrials |
| NCT00188149 | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET | unknown | Phase 4 | 300 | University Hospital Carl Gustav CarusOTHER | 1 | Dec 29, 2005 | clinicaltrials |
| NCT00219752 | Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years | completed | Phase 2 | 30 | Poitiers University HospitalOTHER | 1 | Dec 22, 2005 | clinicaltrials |
| NCT00266370 | A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma | unknown | — | 100 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 19, 2005 | clinicaltrials |
| NCT00224614 | Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia | unknown | Phase 3 | 100 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 14, 2005 | clinicaltrials |
| NCT00262210 | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 6, 2005 | clinicaltrials |
| NCT00219765 | Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients | terminated | Phase 1 / Phase 2 | 30 | Poitiers University HospitalOTHER | 1 | Nov 28, 2005 | clinicaltrials |
| NCT00166855 | Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma | unknown | N/A | 40 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2005 | clinicaltrials |
| NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | unknown | Phase 2 / Phase 3 | 200 | Hannover Medical SchoolOTHER | 1 | Nov 18, 2005 | clinicaltrials |
| NCT00078065 | Xcellerated T CellsTM in Patients With Multiple Myeloma | completed | Phase 2 | 30 | Xcyte TherapiesINDUSTRY | 1 | Nov 11, 2005 | clinicaltrials |
| NCT00078598 | A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma | unknown | Phase 3 | 506 | Corixa CorporationINDUSTRY | 1 | Nov 9, 2005 | clinicaltrials |
| NCT00188084 | Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia | unknown | — | 400 | University Hospital, AngersOTHER_GOV | 1 | Oct 28, 2005 | clinicaltrials |
| NCT00199147 | Efficacy of G-CSF-Priming in Elderly AML Patients | unknown | Phase 4 | 250 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Oct 26, 2005 | clinicaltrials |
| NCT00201318 | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00188370 | Ultrasound Biomicroscopy - Apoptosis | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00168740 | Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102) | completed | Phase 3 | 150 | BiogenINDUSTRY | 2 | Sep 15, 2005 | clinicaltrials |
| NCT00155844 | Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" | unknown | — | 30 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2006source: clinicaltrials